Page results
-
As part of Our National Health Stories, University College London Hospitals NHS Foundation Trust commissioned five poets to write and share stories from the NHS.
-
General cardiology outpatients for local patients are provided by University College Hospital. Specialist and interventional cardiology outpatient services are provided by Barts Heart Centre.
-
This page explains what Post-COVID-19 Syndrome is.
-
Over 150 people visited a highly successful health and research engagement event in Camden which engaged the local community in healthcare innovation, research, and how to stay healthy.
-
A BBC film which looks at the work of scientists at UCL and clinicians at UCLH working together on groundbreaking ‘first in-human’ immunotherapy trials is being shown again on BBC2 tonight.
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
-
Latest issues of our Haematology Life magazine
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
The Government has now set out further action aimed at tackling rising cases of the COVID-19 B1.617.2 variant of COVID-19 (also known as the Indian variant).
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
File results
-
FOI/2022/0123 - Sexual assault allegations in care settings
-
FOI/2022/0124 - Clinical service incidents caused by estates and infrastructure failure
-
FOI/2022/0127 - Provision for treatment of Functional Neurological Disorder (FND)
-
FOI/2022/0134 - Plastic laminating pouches/ sleeves purchased
-
FOI/2022/0140 - Early neo-natal deaths and babies born with serious brain injury
-
FOI/2022/0141 - Idiopathic pulmonary fibrosis (IPF) quality standard
-
FOI/2022/0145 - Head and neck cancer drug treatments
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments